These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15190980)

  • 1. Renal roadblock in managing low output heart failure.
    Leier CV
    Crit Care Med; 2004 May; 32(5):1228-9. PubMed ID: 15190980
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal, but not systemic, hemodynamic effects of dopamine are influenced by the severity of congestive heart failure.
    Ungar A; Fumagalli S; Marini M; Di Serio C; Tarantini F; Boncinelli L; Baldereschi G; Valoti P; La Cava G; Olianti C; Masotti G; Marchionni N
    Crit Care Med; 2004 May; 32(5):1125-9. PubMed ID: 15190961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The case against renal dose dopamine in the pediatric intensive care unit.
    Rice BA; Tanski MC
    AACN Clin Issues; 2005; 16(2):246-51. PubMed ID: 15876891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of adenosine antagonism in the cardio-renal syndrome: pathophysiology and therapeutic potential.
    Rajaram V; Joseph J
    Curr Heart Fail Rep; 2007 Sep; 4(3):153-7. PubMed ID: 17883991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic strategies to preserve renal function in acute decompensated heart failure.
    Kumar S; Taylor DO
    Curr Heart Fail Rep; 2015 Feb; 12(1):1-6. PubMed ID: 25417180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of inotropes.
    Davies N
    Nurs Times; 2001 Jul 19-25; 97(29):36-7. PubMed ID: 11957503
    [No Abstract]   [Full Text] [Related]  

  • 7. Congestion and cardiorenal syndromes.
    Mebazaa A
    Contrib Nephrol; 2010; 165():140-144. PubMed ID: 20427963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cardiorenal connection in heart failure.
    Rastogi A; Fonarow GC
    Curr Cardiol Rep; 2008 May; 10(3):190-7. PubMed ID: 18489862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Non-digitalic cardiac inotropic agents].
    Méndez R
    Arch Inst Cardiol Mex; 1981; 51(3):201-5. PubMed ID: 7283531
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of levosimendan on markers of kidney function in patients with acutely decompensated heart failure and renal impairment.
    Rafouli-Stergiou P; Parissis JT; Farmakis D; Bistola V; Frogoudaki A; Vasiliadis K; Ikonomidis I; Paraskevaidis I; Kremastinos D; Filippatos G; Lekakis J
    J Cardiovasc Med (Hagerstown); 2017 Oct; 18(10):771-773. PubMed ID: 25643197
    [No Abstract]   [Full Text] [Related]  

  • 11. Proposed strategy for optimizing aldosterone blockade in heart failure.
    Jolobe OM
    Am Heart J; 2012 Aug; 164(2):e1; author reply e3. PubMed ID: 22877815
    [No Abstract]   [Full Text] [Related]  

  • 12. Understanding renal dose dopamine.
    Pierce JD; Morris DA; Clancy RL
    J Infus Nurs; 2002; 25(6):365-71. PubMed ID: 12464793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the renal and pulmonary hemodynamic effects of fenoldopam, dobutamine, dopamine and norepinephrine in the anesthetized dog.
    Shebuski RJ; Smith JM; Ruffolo RR
    Pharmacology; 1988; 36(1):35-43. PubMed ID: 2893393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inotropes for the management of acute heart failure patients with renal dysfunction. Still an option?
    Rafouli-Stergiou P; Parissis JT; Anastasiou-Nana M
    Expert Opin Pharmacother; 2012 Dec; 13(18):2637-47. PubMed ID: 23170968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of diastolic heart failure.
    Dhir SK
    Mayo Clin Proc; 2002 Mar; 77(3):295-6. PubMed ID: 11888037
    [No Abstract]   [Full Text] [Related]  

  • 16. [The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation].
    De Vecchis R; Pucciarelli G; Nocerino L; Cocozza M; Setaro A; Torre G; Imperatore F
    Minerva Cardioangiol; 1998 May; 46(5):163-74. PubMed ID: 9842199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Renal dose" dopamine in surgical patients: dogma or science?
    Perdue PW; Balser JR; Lipsett PA; Breslow MJ
    Ann Surg; 1998 Apr; 227(4):470-3. PubMed ID: 9563531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine and the post-cardiac surgery patients: to be considered.
    Lema G
    Acta Anaesthesiol Scand; 2010 Apr; 54(4):525; author reply 525-6. PubMed ID: 20415951
    [No Abstract]   [Full Text] [Related]  

  • 19. Incidence, clinical predictors, and prognostic impact of worsening renal function in elderly patients with chronic heart failure on intensive medical therapy.
    Maeder MT; Rickli H; Pfisterer ME; Muzzarelli S; Ammann P; Fehr T; Hack D; Weilenmann D; Dieterle T; Kiencke S; Estlinbaum W; Brunner-La Rocca HP;
    Am Heart J; 2012 Mar; 163(3):407-14, 414.e1. PubMed ID: 22424011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there still a place for dopamine in the modern intensive care unit?
    Debaveye YA; Van den Berghe GH
    Anesth Analg; 2004 Feb; 98(2):461-468. PubMed ID: 14742388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.